Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Co-Morbidity Score at the Time of Transplant Determines Prognosis in Older Patients Who Develop Acute Graft-Vs.-Host Disease (GVHD).

Amin M Alousi, Gabriela Rondon, Grace-Julia Okoroji, Uday Popat, Leandro De Padua Silva, Sharon Hymes, Joyce Neumann, Nicole M Brunelle, Partow Kebriaei, Chitra Hosing, Issa F Khouri, Elizabeth J Shpall, Muzaffar H Qazilbash, Sergio Giralt, Richard Champlin, Rima M Saliba

Blood (2009) 114 (22): 2244.

https://doi.org/10.1182/blood.V114.22.2244.2244

Published: 2009

Journal Articles

High Prevalence of Vitamin D Deficiency in Allogeneic Stem Cell Transplant Recipients.

Richard W Joseph, Jr., MD, Krishna V. Komanduri, M.D., R. M Saliba, MD, Amin Alousi, MD, S. Giralt, Gabriela Rondon, Joyce Neumann, Cindy Trevino, APN, Daniel R. Couriel, MD, Richard Champlin, U. Popat

Blood (2008) 112 (11): 2138.

https://doi.org/10.1182/blood.V112.11.2138.2138

Published: 2008

Journal Articles

Polyoma (BK) Viruria Prior to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) from Donors Other Than Matched Siblings: A Prospective Evaluation of Hemorrhagic Cystitis (HC) Incidence

Leandro de Padua silva, Poliana Patah, Rima M. Saliba, Nicholas A. Szewczyk, Lisa Gilman, Alison Gulbis, Joyce Neumann, Julia Walker, Demetrios Petropoulos, Rocco LaSala, Kashif Ali Shaz Mir, Yago Nieto, Issa Khouri, Sergio Giralt, Richard E. Champlin, Marcos De Lima

Blood (2008) 112 (11): 50.

https://doi.org/10.1182/blood.V112.11.50.50

Published: 2008

Journal Articles

Hyperacute GVHD: risk factors, outcomes, and clinical implications

Rima M. Saliba, Marcos de Lima, Sergio Giralt, Borje Andersson, Issa F. Khouri, Chitra Hosing, Shubhra Ghosh, Joyce Neumann, Yvonne Hsu, Jorge De Jesus, Muzaffar H. Qazilbash, Richard E. Champlin, Daniel R. Couriel

Blood (2006) 109 (7): 2751–2758.

https://doi.org/10.1182/blood-2006-07-034348

Published: 2006

Journal Articles

Does Polyoma (BK) Virus Contribute to Development of Hemorrhagic Cystitis (HC) in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (UD HSCT) Recipients? A Prospective Evaluation.

Poliana A. Patah, Nicholas A. Szewczyk, Lisa Gilman, Alison Gulbis, Joyce Neumann, Julia A. Walker, Demetrios Petropoulos, Maha El-Zimaity, Paolo Anderlini, Jeffrey Tarrand, Richard E. Champlin, Marcos de Lima

Blood (2006) 108 (11): 5282.

https://doi.org/10.1182/blood.V108.11.5282.5282

Published: 2006

Journal Articles

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

Daniel R. Couriel, Chitra Hosing, Rima Saliba, Elizabeth J. Shpall, Paolo Anderlini, Beverly Rhodes, Veronica Smith, Issa Khouri, Sergio Giralt, Marcos de Lima, Yvonne Hsu, Shubhra Ghosh, Joyce Neumann, Borje Andersson, Muzzafar Qazilbash, Sharon Hymes, Stella Kim, Richard Champlin, Michele Donato

Blood (2006) 107 (8): 3074–3080.

https://doi.org/10.1182/blood-2005-09-3907

Published: 2006

Journal Articles

The Clinical Spectrum of Acute GVHD: Beyond Day 100.

Daniel R. Couriel, MD, Rima Saliba, PhD, Shubhra Gosh, MD, Marcos De Lima, MD, Sergio Giralt, MD, Issa Khouri, MD, Borje Andersson, MD, Kerry Mickler, RN, Zuraima Caldera, MD, Yvonne Hsu, PAC, Joyce Neumann, RN, APN, Sharon Hymes, MD, Stella Kim, MD, Richard Champlin, MD

Blood (2005) 106 (11): 5377.

https://doi.org/10.1182/blood.V106.11.5377.5377

Published: 2005

Journal Articles

Clinical, Prognostic and Therapeutic Implications in the Diagnosis of Grade I Acute Graft-Versus-Host Disease.

Rima M. Saliba, PhD, Marcos de Lima, MD, Chitra Hosing, MD, Issa F. Khouri, MD, Sergio Giralt, MD, Paolo Anderlini, MD, Shubhra Ghosh, MD, Kerry Mickler, RN, Cindy Ippoliti, PHARMD, Zuraima Caldera, MD, Yvonne Hsu, PAC, Joyce Neumann, APN, Richard Champlin, MD, Daniel R. Couriel, MD

Blood (2005) 106 (11): 1799.

https://doi.org/10.1182/blood.V106.11.1799.1799

Published: 2005

Journal Articles

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

Marcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, Munir Shahjahan, Naoto Ueno, Cindy Ippoliti, Borje S. Andersson, James Gajewski, Daniel Couriel, Jorge Cortes, Michele Donato, Joyce Neumann, Richard Champlin, Sergio Giralt

Blood (2004) 104 (3): 865–872.

https://doi.org/10.1182/blood-2003-11-3750

Published: 2004

NARROW

Co-Morbidity Score at the Time of Transplant Determines Prognosis in Older Patients Who Develop Acute Graft-Vs.-Host Disease (GVHD).

High Prevalence of Vitamin D Deficiency in Allogeneic Stem Cell Transplant Recipients.

Polyoma (BK) Viruria Prior to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) from Donors Other Than Matched Siblings: A Prospective Evaluation of Hemorrhagic Cystitis (HC) Incidence

Hyperacute GVHD: risk factors, outcomes, and clinical implications

Does Polyoma (BK) Virus Contribute to Development of Hemorrhagic Cystitis (HC) in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (UD HSCT) Recipients? A Prospective Evaluation.

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

The Clinical Spectrum of Acute GVHD: Beyond Day 100.

Clinical, Prognostic and Therapeutic Implications in the Diagnosis of Grade I Acute Graft-Versus-Host Disease.

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only